Evidence map›Paper›PMID 36836359›Full record

ArticleJournal of fungi (Basel, Switzerland)2023

Biodistribution and Adjuvant Effect of an Intranasal Vaccine Based on Chitosan Nanoparticles against Paracoccidioidomycosis.

Samuel Rodrigues Dos Santos Júnior, Filipe Vieira Barbalho, Joshua D Nosanchuk, Andre Correa Amaral, Carlos Pelleschi Taborda

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Journal of fungi (Basel, Switzerland) · 2025
    Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Samuel Rodrigues Dos Santos JúniorLaboratory of Pathogenic Dimorphic Fungi, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508000, Brazil.ORCID 0000-0001-5564-3538
Filipe Vieira BarbalhoLaboratory of Pathogenic Dimorphic Fungi, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508000, Brazil.
Joshua D NosanchukDepartment of Medicine and Department of Microbiology and Immunology-The Bronx, Albert Einstein College of Medicine, New York, NY 10461, USA.
Andre Correa AmaralLaboratory of Nano&Biotechnology, Department of Biotechnology, Institute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia 74605050, Brazil.
Carlos Pelleschi TabordaLaboratory of Pathogenic Dimorphic Fungi, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508000, Brazil.ORCID 0000-0001-9928-9809
Universidade de São Paulo · BRAlbert Einstein College of Medicine · USUniversidade Federal de Goiás · BR

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 88882.333055/2019-01National Council for Scientific and Technological Development 134424/2016-6National Council for Scientific and Technological Development 420480/2018-8São Paulo Research Foundation 2016/08730-6
6 · The paper itself

Abstract

Paracoccidioidomycosis (PCM) is a fungal infection caused by the thermodimorphic

Indexed as

adjuvant nanoparticleschitosan nanoparticlesfluorescent nanoparticlesintranasal vaccinePCM

Identifiers

PMID36836359
PMCPMC9964167
OpenAlexW4320492442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.